From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

I will not be losing my Lloyds Bank shareholder virginity status

By Chris Bailey | Thursday 27 October 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


I have never admitted this publicly before, but when I was 18 and setting up a university bank account I wanted one at Lloyds Bank (LLOY). However, it never worked out and I ended up with one of its competitors (absolutely nothing to do with the extra ten quid offered as a “joining bonus”). And, funnily enough, I have never owned Lloyds Bank plc shares either during my investment life, as there was always something potentially better or more interesting or something else. Nevertheless, I listened to the group’s conference call earlier today for a bit of light corporate earnings season excitement. What did I make of the “fast evolving and uncertain environment”, where apparently “the group is performing well”?

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 09:18:25